Marjukka Anttila (M Anttila)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Cancer gene therapy

Animals : an open access journal from MDPI

Oncoimmunology

PLoS genetics

Finnish Food Authority

Cornell University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Finnish Food Authority Apr 01 1988

Finland

Professor :: Pathology

Education History

Cornell University Sep 01 1983 - Mar 31 1988

United States

PHD :: Pathology

Publications

Hertta Pirkkalainen, Aino Riihimäki, Taru Lienemann, Marjukka Anttila, Minna Kujala-Wirth, Päivi Rajala-Schultz, Heli Simojoki, Timo Soveri, Toomas Orro
Local and Systemic Inflammation in Finnish Dairy Cows with Digital Dermatitis. Animals : an open access journal from MDPI 14 (3) (2024)
Hertta Pirkkalainen, Aino Riihimäki, Taru Lienemann, Marjukka Anttila, Minna Kujala-Wirth, Päivi Rajala-Schultz, Heli Simojoki, Timo Soveri, Toomas Orro
Local and Systemic Inflammation in Finnish Dairy Cows with Digital Dermatitis. Animals : an open access journal from MDPI 14 (3) (2024)
Dafne C A Quixabeira, E Jirovec, Santeri A Pakola, R Havunen, S Basnet, J M Santos, Tatiana Viktorovna Kudling, J H A Clubb, L Haybout, V Arias, S Grönberg-Vähä-Koskela, V Cervera-Carrascon, Annukka Pasanen, Marjukka Anttila, J Tapper, A Kanerva, Akseli E Hemminki
Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine. Cancer gene therapy (2023)
Dafne C A Quixabeira, Santeri A Pakola, E Jirovec, R Havunen, S Basnet, J M Santos, Tatiana Viktorovna Kudling, J H A Clubb, L Haybout, V Arias, S Grönberg-Vähä-Koskela, V Cervera-Carrascon, Erja Kerkelä, Annukka Pasanen, Marjukka Anttila, J Tapper, A Kanerva, Akseli E Hemminki
Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer. Cancer gene therapy (2023)
Dafne C A Quixabeira, Victor Cervera-Carrascon, Joao M Santos, James H A Clubb, Tatiana Viktorovna Kudling, Saru Basnet, Camilla Heiniö, Susanna Grönberg-Vähä-Koskela, Marjukka Anttila, Riikka Havunen, Anna Kanerva, Akseli E Hemminki
Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1. Oncoimmunology 11 (1) (2022)
Marjo K Hytönen, Riika Sarviaho, Christopher B Jackson, Pernilla Syrjä, Tarja S Jokinen, Kaspar Matiasek, Marco Rosati, Cristina Dallabona, Enrico Baruffini, Ileana Quintero, Meharji Arumilli, Geoffray Monteuuis, Jonas Donner, Marjukka Anttila, Anu Suomalainen, Laurence Albert Bindoff, Hannes T Lohi
In-frame deletion in canine PITRM1 is associated with a severe early-onset epilepsy, mitochondrial dysfunction and neurodegeneration. Human genetics 140 (11) (2021)
Riikka Havunen, Riikka Kalliokoski, Mikko Siurala, Suvi Sorsa, João M Santos, Victor Cervera-Carrascon, Marjukka Anttila, Akseli Hemminki
Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1. Cells 10 (2) (2021)
Kati J Dillard, Matthias Ochs, Julia E Niskanen, Meharji Arumilli, Jonas Donner, Kaisa Kyöstilä, Marjo K Hytönen, Marjukka Anttila, Hannes T Lohi
Recessive missense LAMP3 variant associated with defect in lamellar body biogenesis and fatal neonatal interstitial lung disease in dogs. PLoS genetics 16 (3) (2020)
Kati J Dillard, Marjo K Hytönen, Daniel Fischer, Kimmo Tanhuanpää, Mari S Lehti, Katri Vainio-Siukola, Anu Sironen, Marjukka Anttila
A splice site variant in INPP5E causes diffuse cystic renal dysplasia and hepatic fibrosis in dogs. PloS one 13 (9) (2018)

Marjukka Anttila.css-eqlu8i{font-size:small;padding-left:4px;} (M Anttila)

Publication Activity (10 Years)

Top Topics

Top Venues

Marjukka Anttila (M Anttila)